Literature DB >> 984690

The importance of plasma fibrinogen in vascular surgery.

J C Postlethwaite.   

Abstract

The plasma fibrinogen concentration is directly related to blood viscosity, which in turn is inversely related to blood flow. The way in which the plasma fibrinogen level affects the clinical status of patients with peripheral vascular disease is discussed with reference to both retrospective and prospective studies of patients undergoing major arterial surgery. Animal experiments are described in which the effect of reducing the plasma fibrinogen level with oral clofibrate and parenteral Arvin (ancrod) on the patency of Dacron arterial grafts was studied.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 984690      PMCID: PMC2491878     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  7 in total

1.  Results of ankle ststolic pressure measurements in patients with intermittent claudication being treated with clofibrate.

Authors:  J C Postlethwaite; J A Dormandy
Journal:  Ann Surg       Date:  1975-06       Impact factor: 12.969

2.  The paradox in therapeutic defibrination.

Authors:  H A Reid; K E Chan
Journal:  Lancet       Date:  1968-03-09       Impact factor: 79.321

Review 3.  An experimental and clinical evaluation of grafts in the venous system.

Authors:  H Haimovici; P W Hoffert; N Zinicola; C Steinman
Journal:  Surg Gynecol Obstet       Date:  1970-12

4.  Prognostic significance of rheological and biochemical findings in patients with intermittent claudication.

Authors:  J A Dormandy; E Hoare; A H Khattab; D E Arrowsmith; T L Dormandy
Journal:  Br Med J       Date:  1973-12-08

5.  Influence of blood viscosity on blood flow and the effect of low molecular weight dextran.

Authors:  J A Dormandy
Journal:  Br Med J       Date:  1971-12-18

6.  Plasma-fibrinogen after replacement of heart valves by grafts and prostheses.

Authors:  Y Tessier; P Littleton; H Collet; J Marshall; L McDonald
Journal:  Lancet       Date:  1971-01-02       Impact factor: 79.321

7.  Secondary prevention trials using clofibrate: a joint commentary on the Newcastle and Scottish trials.

Authors:  H A Dewar; M F Oliver
Journal:  Br Med J       Date:  1971-12-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.